Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Connie Wang

Dermatology Katy, TX Medical Doctor

NPI 1003250457 CMS profile 226648

4603 Fm 1463 Rd Ste 100, Katy, TX 77494

Open in the dashboard

General payments

$49,371

1,149 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Connie Wang of Katy, TX is reported in the CMS Open Payments database as having received $49,371 across 1,149 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,650 186
2024 General $3,571 150
2023 General $2,838 192
2022 General $21,421 165
2021 General $13,149 182
2020 General $1,756 103
2019 General $2,986 171

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Connie Wang
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Connie Wang were reported at $3,650. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Connie Wang Dermatology median Middle half National median
2019 $2,986 $454 $129–$1,240 $163
2020 $1,756 $235 $81–$756 $114
2021 $13,149 $377 $108–$1,108 $132
2022 $21,421 $514 $143–$1,391 $149
2023 $2,838 $607 $159–$1,674 $160
2024 $3,571 $751 $204–$1,903 $164
2025 $3,650 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $28,973 28 payments
  2. AbbVie, Inc. $2,261 148 payments
  3. Galderma Laboratories, L.P. $1,920 83 payments
  4. Regeneron Healthcare Solutions, Inc. $1,742 81 payments
  5. Revance Therapeutics, Inc. $1,689 24 payments
  6. Novartis Pharmaceuticals Corporation $1,471 139 payments
  7. Janssen Biotech, Inc. $1,409 62 payments
  8. Mayne Pharma Inc. $1,160 168 payments
  9. Genzyme Corporation $1,038 33 payments
  10. Lilly USA, LLC $972 51 payments
  11. Other $6,737 332 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $28,615 6 payments
  2. Food and Beverage $20,011 1,137 payments
  3. Education $395 5 payments
  4. Consulting Fee $350 1 payment
Products named General payments · program years 2019–2025
  1. DAXXIFY $1,568 23 payments
  2. DUPIXENT Inflammation And Immunology $1,480 69 payments
  3. TREMFYA $1,271 48 payments
  4. DUPIXENT Immunology $1,179 37 payments
  5. SKYRIZI $1,032 59 payments
  6. TALTZ $799 47 payments
  7. Otezla $752 43 payments
  8. COSENTYX $722 67 payments
  9. EUCRISA $556 31 payments
  10. Zoryve $553 31 payments
  11. Other $11,840 685 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

191

Median for Dermatology: 534

Drug cost

$108,730

Median for Dermatology: $67,151

Branded share of claims

7.3%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Taltz Autoinjector Ixekizumab Brand 14 $104,656
Clobetasol Propionate Generic 15 $1,012
Fluorouracil Generic 11 $681
Ketoconazole Generic 46 $653
Triamcinolone Acetonide Generic 46 $587
Clindamycin Phosphate Generic 11 $366
Doxycycline Monohydrate Generic 12 $321
Fluocinonide Generic 12 $285
Minoxidil Generic 11 $94
Doxycycline Hyclate Generic 13 $75

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$94,421

Medicare's payments for the services billed

Medicare patients

199

Average age 72

Services billed

1,245

111 women, 88 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 60%
Arthritis 43%
Ischemic heart disease 26%
Osteoporosis 15%
Diabetes 14%
Depression 14%
Cancer 13%
Chronic kidney disease 12%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 29 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DAXXIFY
$852 — —
DUPIXENT
$500 — —
SKYRIZI
$259 — —
TREMFYA
$226 — —
Zoryve
$210 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 29 with Patron

Records

1,149 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record